Immunogenicity and safety of mumps vaccine in healthy adults: a single institute based cohort study

Immunogenicity and safety of mumps vaccine in healthy adults: a single institute based cohort study - Immunogenicity and safety of mumps vaccine in healthy adults

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043588

Enrollment

Registered

2021-03-12

Start date

2021-01-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mumps virus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Person who had not complete 2 dosed of mumps vaccination yet

Exclusion criteria

Exclusion criteria: Person who had completed 2 dosed of mumps vaccination

Design outcomes

Primary

Measure	Time frame
Antibody	—

Secondary

Measure	Time frame
Local reaction	—

Countries

Japan

Contacts

Public ContactMegumi Hara

Saga university Preventive medicine

harameg@cc.saga-u.ac.jp0952-34-2289

Outcome results